SCHEMBL10951354

SCHEMBL10951354

CCOC(=O)c1ccc(NC(=O)CP(=O)(OCC)OCC)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.63
▸ RAB9A P51151 6/20 0.62
▸ GAA P10253 4/20 0.59
▸ SMN1; SMN2 Q16637 6/20 0.58
▸ NPC1 O15118 3/20 0.58
▸ MEN1 O00255 7/20 0.57
▸ KMT2A Q03164 7/20 0.57
▸ ALDH1A1 P00352 4/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ MAPT P10636 3/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ CASP3 P42574 1/20 0.55
▸ TRPV1 Q8NER1 1/20 0.55
▸ SENP7 Q9BQF6 1/20 0.55
▸ TP53 P04637 1/20 0.55
▸ POLB P06746 1/20 0.55
▸ KDM4E B2RXH2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2403850 0.90 MEN1 (0.62) TSHRRAB9AGAANPC1MEN1
SCHEMBL2406730 0.84 KMT2A (0.65) TSHRRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL5598097 0.81 MEN1 (0.54) SMN1; SMN2MEN1KMT2AALDH1A1MAPT
SCHEMBL10952765 0.81 NPSR1 (0.53) RAB9AGAASMN1; SMN2NPC1ALDH1A1
SCHEMBL9671985 0.81 TSHR (0.77) TSHRRAB9AGAASMN1; SMN2NPC1
SCHEMBL2840870 0.79 TSHR (0.74) TSHRRAB9AGAASMN1; SMN2NPC1
SCHEMBL2840873 0.79 TSHR (0.74) TSHRRAB9AGAASMN1; SMN2NPC1
SCHEMBL12319372 0.79 POLB (0.42) TSHRGAASMN1; SMN2MEN1KMT2A
SCHEMBL13966687 0.79 NPC1 (0.53) RAB9AGAASMN1; SMN2NPC1MEN1
SCHEMBL5879030 0.79 RAB9A (0.88) TSHRRAB9AGAASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4536346-A TREATMENT OF ATHEROSCLEROSIS AMERICAN CYANAMID COMPANY (US) 1985-08-20 — — US disclosed
US-4489090-A ATHEROSCLEROSIS AMERICAN CYANAMID COMPANY (US) 1984-12-18 — — US disclosed
EP-0124791-A1 Aralkanamidophenyl compounds AMERICAN CYANAMID COMPANY (US) 1984-11-14 — — EP disclosed
Send feedback